Cefga CS 500mg/250mg Injection
Marketer
Auriga Labs
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefga CS 500mg/250mg Injection
Cefga CS, a 500mg/250mg injectable dual-action medication, combats bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional. Complete the prescribed regimen; premature cessation may compromise effectiveness. Missed doses should be avoided. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent reactions require immediate medical attention. Allergic responses (rash, itching, edema, dyspnea) necessitate urgent medical care. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the medicine's efficacy.
Primary Ingredients of Cefga CS 500mg/250mg Injection
The provided text is "undefined". Therefore, no rephrasing is possible.
Uses of Cefga CS 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefga CS 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefga CS 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefga CS 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefga CS 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefga CS 500mg/250mg Injection, offer a dual-action approach to bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefga CS 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefga CS (500mg/250mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human studies remain scarce.
Breast feedingCAUTION
Administration of Cefga CS 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefga CS 500mg/250mg Injection can induce drowsiness, visual disturbances, and dizziness. Operation of a motor vehicle is contraindicated while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefga CS 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Cefga CS (500mg/250mg) requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Patients should seek medical advice. Dosage alteration for Cefga CS (500mg/250mg) injection is not advised for those with mild or moderate liver dysfunction.
What if you forget to take Cefga CS 500mg/250mg Injection :
Omitting a scheduled dose of Cefga CS 500mg/250mg Injection warrants immediate physician consultation.
Facts to Know About Cefga CS 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently